These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1648700)

  • 21. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of AKT-regulated genes in inducible MERAkt cells.
    Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
    Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue specificity of oncogene action: endothelial cell tumours in polyoma middle T transgenic mice.
    Bautch VL; Toda S; Hassell JA; Hanahan D
    IARC Sci Publ; 1989; (96):255-66. PubMed ID: 2807487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene.
    Talmage DA; Listerud M
    Oncogene; 1994 Dec; 9(12):3557-63. PubMed ID: 7970716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of c-fos, c-jun, and c-myc genes is regulated by heat shock in human lymphoid cells.
    Bukh A; Martinez-Valdez H; Freedman SJ; Freedman MH; Cohen A
    J Immunol; 1990 Jun; 144(12):4835-40. PubMed ID: 2112575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of polyomavirus middle T domain that is responsible for AP-1 activation.
    Oliveira ML; Roberts TM; Druker BJ; Armelin MC
    Oncogene; 1998 Jun; 16(23):2975-82. PubMed ID: 9662329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective induction of c-jun and jun-B but not c-fos or c-myc during mitogenesis in SV40-transformed cells at the predifferentiation growth arrest state.
    Wang H; Wang JY; Johnson LR; Scott RE
    Cell Growth Differ; 1991 Dec; 2(12):645-52. PubMed ID: 1667087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
    Cory JG; He AW; Cory AH
    Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of protooncogenes during lymphocyte activation by growth factors.
    Bulanova EG; Budagyan VM; Yarilin AA; Mazurenko NN
    Biochemistry (Mosc); 1997 Sep; 62(9):1021-5. PubMed ID: 9457764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
    Touray M; Ryan F; Jaggi R; Martin F
    Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyomavirus-induced malignant transformation: comparative analysis of wild type and mutant middle T-overexpressing cell lines.
    Armelin MC; Oliveira ML
    Braz J Med Biol Res; 1996 Sep; 29(9):1133-40. PubMed ID: 9181056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of cytokeratin 14 mRNA in polyoma virus middle T-transformed rat liver epithelial cells.
    Royal I; Gourdeau H; Blouin R; Marceau N
    Cell Growth Differ; 1992 Sep; 3(9):589-96. PubMed ID: 1384655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proto-oncogene amplification and overexpression in cadmium-induced cell transformation.
    Spruill MD; Song B; Whong WZ; Ong T
    J Toxicol Environ Health A; 2002 Dec; 65(24):2131-44. PubMed ID: 12515591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of early-response genes during polyomavirus infection.
    Glenn GM; Eckhart W
    J Virol; 1990 May; 64(5):2193-201. PubMed ID: 1691311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of in vitro muscle differentiation by the immortalizing oncogene py LT-ag.
    Maione R; Fimia GM; Amati P
    Symp Soc Exp Biol; 1992; 46():53-71. PubMed ID: 1341050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src.
    Barone MV; Courtneidge SA
    Nature; 1995 Nov; 378(6556):509-12. PubMed ID: 7477410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.